Genetic and epigenetic determinants of vitamin D metabolism: nutrigenomic insights for precision nutrition
Abstract
Vitamin D plays a pivotal role in immune regulation, metabolic balance, skeletal health, and gene expression. Growing evidence indicates that genetic and epigenetic factors contribute to interindividual differences in vitamin D status and physiological responses. This review summarizes current findings on the nutrigenomic determinants of vitamin D metabolism, with emphasis on genetic polymorphisms in vitamin D receptor (VDR), GC, CYP2R1, CYP27B1, and CYP24A1, as well as epigenetic mechanisms that modulate vitamin D related gene expression. Peer-reviewed original studies and review articles published between 2010 and 2025 were examined to highlight associations between genetic variation in the vitamin D pathway and susceptibility to cancer, autoimmune disorders, metabolic diseases, cardiovascular conditions, and neurodegenerative outcomes. Advances in omics technologies and epigenetic biomarker research have improved understanding the molecular pathways through which vitamin D acts across multiple body systems. Evidence from gene-environment interactions and genotype-specific supplementation responses highlights the conceptual relevance of precision nutrition, while underscoring substantial gaps in clinical validation. Collectively, current research suggests that genetic information may inform future personalized vitamin D strategies, although translation into clinical practice remains limited by inconsistent evidence and methodological heterogeneity.
Read the paper
Related studies
- Effectiveness of Bisphosphonates and Denosumab on Risk of Vertebral Fractures in Prostate Cancer Patients Under Androgen Deprivation Therapies: A Real-World Prospective Study
- Osteoporosis-related fractures after spinal cord injury: a retrospective study from Brazil
- Serum 25-hydroxyvitamin D, parathyroid hormone, and mortality in older men
- Lack of Association between Vitamin D Insufficiency and Cardiovascular or Fracture Risk: A UK Biobank Study
- Muscle strength and body composition are clinical indicators of osteoporosis
- Incidence of bone protection and associated fragility injuries in patients with proximal femur fractures
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.